CO7160002A2 - Métodos para preparar triazolopiridinas sustituidas - Google Patents

Métodos para preparar triazolopiridinas sustituidas

Info

Publication number
CO7160002A2
CO7160002A2 CO15004251A CO15004251A CO7160002A2 CO 7160002 A2 CO7160002 A2 CO 7160002A2 CO 15004251 A CO15004251 A CO 15004251A CO 15004251 A CO15004251 A CO 15004251A CO 7160002 A2 CO7160002 A2 CO 7160002A2
Authority
CO
Colombia
Prior art keywords
methods
preparing substituted
substituted triazolopyridines
preparing
triazolopyridines
Prior art date
Application number
CO15004251A
Other languages
English (en)
Spanish (es)
Inventor
Volker Klaus Schulze
Franz Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CO7160002A2 publication Critical patent/CO7160002A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO15004251A 2012-07-10 2015-01-09 Métodos para preparar triazolopiridinas sustituidas CO7160002A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05

Publications (1)

Publication Number Publication Date
CO7160002A2 true CO7160002A2 (es) 2015-01-15

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
CO15004251A CO7160002A2 (es) 2012-07-10 2015-01-09 Métodos para preparar triazolopiridinas sustituidas

Country Status (24)

Country Link
US (1) US9388177B2 (en:Method)
EP (1) EP2872506A1 (en:Method)
JP (1) JP6238979B2 (en:Method)
KR (1) KR20150040845A (en:Method)
CN (1) CN104603136B (en:Method)
AP (1) AP3778A (en:Method)
AU (1) AU2013289381A1 (en:Method)
BR (1) BR112015000308A2 (en:Method)
CA (1) CA2878481A1 (en:Method)
CL (1) CL2015000038A1 (en:Method)
CO (1) CO7160002A2 (en:Method)
CR (1) CR20150006A (en:Method)
DO (1) DOP2015000007A (en:Method)
EA (1) EA027544B1 (en:Method)
HK (1) HK1206731A1 (en:Method)
IL (1) IL236265A (en:Method)
IN (1) IN2015DN00085A (en:Method)
MX (1) MX2015000348A (en:Method)
NZ (1) NZ703020A (en:Method)
PE (1) PE20150354A1 (en:Method)
PH (1) PH12015500061A1 (en:Method)
SG (1) SG11201408419QA (en:Method)
TN (1) TN2015000008A1 (en:Method)
WO (1) WO2014009219A1 (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105431435A (zh) * 2013-06-07 2016-03-23 拜耳制药股份公司 具有作为mps-1抑制剂的活性的取代的三唑并吡啶类
PL3008062T3 (pl) * 2013-06-11 2017-08-31 Bayer Pharma Aktiengesellschaft Pochodne proleki podstawionych triazolopirydyn
AU2014280354A1 (en) 2013-06-11 2015-12-03 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer comprising a Mps-1 kinase inhibitor and a mitotic inhibitor
WO2016166255A1 (en) 2015-04-17 2016-10-20 Netherlands Translational Research Center B.V. Prognostic biomarkers for ttk inhibitor chemotherapy
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003030937A1 (ja) * 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
US20060074102A1 (en) * 2004-05-14 2006-04-06 Kevin Cusack Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
WO2006038116A2 (en) * 2004-10-07 2006-04-13 Warner-Lambert Company Llc Triazolopyridine derivatives as antibacterial agents
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
AR061229A1 (es) * 2006-06-06 2008-08-13 Schering Corp Imidazopirazinas como inhibidores de la proteina quinasa
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
MX2009002171A (es) 2006-08-30 2009-05-28 Cellzome Ltd Derivados de triazol como inhibidores de cinasas.
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
JP2010533680A (ja) 2007-07-18 2010-10-28 ノバルティス アーゲー 二環ヘテロアリール化合物およびそれらのキナーゼ阻害剤としての使用
US20110118238A1 (en) 2007-08-23 2011-05-19 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
MX2010002312A (es) 2007-08-31 2010-03-18 Merck Serono Sa Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis.
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
US8530689B2 (en) * 2008-05-05 2013-09-10 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
EP2303890A4 (en) * 2008-06-19 2012-04-11 Progenics Pharm Inc INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
MX2011008549A (es) 2009-02-13 2011-12-06 Fovea Pharmaceuticals [1, 2, 4] triazolo [1 ,5 -a] piridinas como inhibidores de cinasa.
CN102413831B (zh) 2009-04-29 2014-06-04 拜耳知识产权有限责任公司 取代的咪唑并喹喔啉
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
CN102459258B (zh) * 2009-06-05 2015-11-25 赛福伦公司 1,2,4-三唑并[1,5a]吡啶衍生物的制备和用途
WO2011026579A1 (en) 2009-09-04 2011-03-10 Bayer Schering Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343294A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
EA023766B1 (ru) * 2011-04-21 2016-07-29 Байер Интеллектчуал Проперти Гмбх Триазолопиридины
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
IN2015DN00085A (en:Method) 2015-05-29
AU2013289381A1 (en) 2015-01-22
TN2015000008A1 (en) 2016-06-29
SG11201408419QA (en) 2015-01-29
US20150148542A1 (en) 2015-05-28
KR20150040845A (ko) 2015-04-15
WO2014009219A1 (en) 2014-01-16
AP3778A (en) 2016-08-31
CR20150006A (es) 2015-02-16
HK1206731A1 (en) 2016-01-15
PH12015500061A1 (en) 2015-03-02
EA201590116A1 (ru) 2015-07-30
IL236265A (en) 2017-07-31
MX2015000348A (es) 2015-04-14
DOP2015000007A (es) 2015-02-15
EA027544B1 (ru) 2017-08-31
EP2872506A1 (en) 2015-05-20
BR112015000308A2 (pt) 2017-06-27
JP6238979B2 (ja) 2017-11-29
JP2015523372A (ja) 2015-08-13
US9388177B2 (en) 2016-07-12
PE20150354A1 (es) 2015-03-21
CN104603136B (zh) 2017-06-27
NZ703020A (en) 2017-08-25
CN104603136A (zh) 2015-05-06
AP2014008177A0 (en) 2014-12-31
CA2878481A1 (en) 2014-01-16
IL236265A0 (en) 2015-02-26
CL2015000038A1 (es) 2015-03-13

Similar Documents

Publication Publication Date Title
CR20140463A (es) Compuestos de heterociclilo como inhibidores de mek
CR20130539A (es) Triazolopiridinas
MX2016004933A (es) Inhibidores de pirimidina del fgfr4.
CL2016001733A1 (es) Compuestos intermediarios para la preparación de compuestos derivados de piperidinona como inhibidores mdm2 para el tratamiento de cáncer div. sol. 3415-12.
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
AR091837A1 (es) Compuestos para inmunoterapia dirigida
UY34472A (es) Derivados modificados de 4-fenil-piridina
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
UY34523A (es) Derivados de betulina
UY34654A (es) Inhibidores de la beta-secretasa
CR20120637A (es) Triazolopiridinas sustituidas
CU20160004A7 (es) Bencil-1 h-pirazolo[3,4-b]piridinas
UY33977A (es) Híbrido de pigmento autoaglutinante.
DOP2015000059A (es) Amino-quinolinas como inhibidores de cinasa
UY35626A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
DOP2015000060A (es) Profármacos de aminoquinazolina inhibidora de cinasa
LT3495495T (lt) Diagnostiniai žymenys ląstelių proliferacijos sutrikimų gydymui telomerazės inhibitoriais
BR112014026634A2 (pt) direcionador
MX2014015039A (es) Inhibidores de fbx03.
UY34612A (es) ?procedimiento para la preparación de derivados de isoxazolina azetidina quirales como agentes antiparasitarios?.
NI201200195A (es) Procedimiento de preparación de la sal de l - arginina de perindoprilo
BR112015001072A2 (pt) misturas refrigerantes
BR112014027219A2 (pt) método
CO7160002A2 (es) Métodos para preparar triazolopiridinas sustituidas
UY34286A (es) Diagnóstico de vacuna mejorado